UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000038646
Receipt number R000044034
Scientific Title The relationship between arterial function and the ability to produce equol in menopausal or postmenopausal women: focused on intestinal microbiome.
Date of disclosure of the study information 2019/12/01
Last modified on 2020/09/08 17:47:33

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

The relationship between arterial function and the ability to produce equol in menopausal or postmenopausal women: focused on intestinal microbiome.

Acronym

The relationship between arterial function and the ability to produce equol in menopausal or postmenopausal women: focused on intestinal microbiome.

Scientific Title

The relationship between arterial function and the ability to produce equol in menopausal or postmenopausal women: focused on intestinal microbiome.

Scientific Title:Acronym

The relationship between arterial function and the ability to produce equol in menopausal or postmenopausal women: focused on intestinal microbiome.

Region

Japan


Condition

Condition

Healthy adults

Classification by specialty

Adult

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

The purpose of this study is to clarify the relationship between equol production, arterial function, dietary factors, and lifestyle habits in menopausal or postmenopausal women, focusing on the gut microbiota.

Basic objectives2

Others

Basic objectives -Others

Observational study

Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

The objective of this study is to clarify the relationship among arterial function, the ability to produce equol, dietary factors, and lifestyle habits in menopausal or postmenopausal women, focused on intestinal microbiome.

Key secondary outcomes



Base

Study type

Interventional


Study design

Basic design

Single arm

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

Uncontrolled

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

1

Purpose of intervention

Prevention

Type of intervention

Food

Interventions/Control_1

Taking foods contained soy isoflavones for 3 days.

Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

40 years-old <=

Age-upper limit

64 years-old >=

Gender

Female

Key inclusion criteria

1. Subjects who are menopause period or post-menopause within 5 years (self-assessment information).
2. Subjects whose written informed consent has been obtained by her voluntary participations.
3. Subjects whose do not have serious cerebrovascular disease, heart disease, liver disease, kidney disease, digestive system disease, and infectious disease.

Key exclusion criteria

1. Subject who have soy allergies.
2. Subject who have hormone replacement therapy
3. Subject who have the disease that need to have medical treatment, given drugs, receiving general lifestyle guidance, and who are judged as unsuitable for the current study by the principal investigator.
4. Subject who is participating in other clinical trial, or have participated in other clinical trial within 30 days before the informed for consent this study.
5. Subject who is HBV, HCV, or HIV positive in the blood test of this study.
6. Subjects who have been determined ineligible by principal investigator.

Target sample size

50


Research contact person

Name of lead principal investigator

1st name Yuko
Middle name
Last name TOUSEN

Organization

National Institutes of Biomedical Innovation, Health and Nutrition

Division name

Department of Food Function and Labeling

Zip code

162-8636

Address

1-23-1 Toyama, Shinjuku-ku,Tokyo

TEL

03-3203-8063

Email

tousen@nibiohn.go.jp


Public contact

Name of contact person

1st name Yuko
Middle name
Last name TOUSEN

Organization

National Institutes of Biomedical Innovation, Health and Nutrition

Division name

Department of Food Function and Labeling

Zip code

162-8636

Address

1-23-1 Toyama, Shinjuku-ku, Tokyo

TEL

03-3203-8063

Homepage URL


Email

tousen@nibiohn.go.jp


Sponsor or person

Institute

National Institutes of Biomedical Innovation, Health and Nutrition

Institute

Department

Personal name



Funding Source

Organization

DANON Institute of Japan Foundation

Organization

Division

Category of Funding Organization

Non profit foundation

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Ethical Committee of National Institutes of Biomedical Innovation, Health and Nutrition

Address

7-6-8 Saitoasagi, Ibaraki, Osaka

Tel

072-641-9829

Email

irb-office@nibiohn.go.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2019 Year 12 Month 01 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Suspended

Date of protocol fixation

2019 Year 08 Month 22 Day

Date of IRB

2019 Year 11 Month 11 Day

Anticipated trial start date

2019 Year 12 Month 01 Day

Last follow-up date

2022 Year 03 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2019 Year 11 Month 20 Day

Last modified on

2020 Year 09 Month 08 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000044034


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name